BARCLAYS PLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 1 filers reported holding SUMMIT THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$277
+130.8%
148,016
+206.6%
0.00%
Q2 2023$120
-72.2%
48,272
-80.4%
0.00%
Q1 2023$432
+632.2%
246,464
+1678.4%
0.00%
Q4 2022$59
-97.0%
13,859
+563.4%
0.00%
Q3 2022$2,000
+100.0%
2,089
+85.2%
0.00%
Q2 2022$1,000
-90.9%
1,128
-74.1%
0.00%
Q1 2022$11,0004,3610.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Polar Capital Holdings Plc 6,961,913$51,936,0000.23%
LEVIN CAPITAL STRATEGIES, L.P. 38,762$289,0000.03%
Riverview Trust Co 1,000$7,0000.01%
HoyleCohen, LLC 10,432$78,0000.01%
Baillie Gifford 436,512$3,256,0000.00%
Tower Research Capital LLC (TRC) 3,436$26,0000.00%
Renaissance Technologies 125,452$936,0000.00%
ProShare Advisors LLC 23,304$174,0000.00%
Bradley & Co. Private Wealth Management, LLC 200$1,0000.00%
FIL Ltd 104,100$777,0000.00%
View complete list of SUMMIT THERAPEUTICS INC shareholders